Related Experiment Video
Updated: Nov 19, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Cardiac manifestation of corona virus disease 2019: a preliminary report
G T Lasisi1, A O Duro-Emanuel1, T E Akintomide2
1Department of Medicine, General Hospital Ifako-Ijaiye, Lagos, Nigeria.
Insights
This study highlights common cardiac complications in Nigerian COVID-19 patients, with heart failure being the most frequent. Many patients had underlying conditions like hypertension and diabetes, alongside elevated inflammatory markers.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) is a multi-systemic illness.
- Cardiac complications are a significant manifestation of COVID-19.
- This study focuses on preliminary findings from Lagos, Nigeria.
Purpose of the Study:
- To describe cardiac manifestations in COVID-19 patients managed in Lagos, Nigeria.
- To investigate the prevalence of cardiac complications in this patient cohort.
Main Methods:
- Retrospective study of ten COVID-19 patients.
- Patients diagnosed via RT-PCR or serology.
- Cardiac manifestations were assessed in patients admitted to three centers.
Main Results:
- Mean age was 52.5 years; 60% were female.
- High prevalence of comorbidities: hypertension (70%), diabetes (50%), obesity (60%).
- Commonest cardiac manifestation was heart failure (six de novo, one decompensated); others included myocarditis, pulmonary embolism, and stress cardiomyopathy.
Conclusions:
- Comorbidities are frequent in COVID-19 patients with cardiac complications.
- A wide spectrum of cardiac issues can occur, with heart failure being the most prevalent.
- Findings underscore the importance of monitoring cardiac health in COVID-19 patients, especially those with pre-existing conditions.
Background:
Corona virus disease 2019 (COVID-19) is a multi-systemic illness that can present with cardiac complications. This report describes the preliminary findings of cardiac manifestations seen in patients managed in three centres in Lagos, Nigeria.
Methods:
Ten patients, part of an ongoing study of patients admitted in three centres in Lagos, Nigeria, with COVID-19 diagnosed with reverse transcriptase polymerase chain reaction (RT-PCR) or serology were retrospectively studied for cardiac manifestations.
Results:
The mean (SD) age was 52.5 ± 18.79 years (with a minimum of 17 years and maximum of 79 years). Six patients were female and four were male. Hypertension was seen in 70%, diabetes in 50% and obesity in 60% of patients. All had elevated inflammatory markers. Only four patients had bilateral pneumonia. The rest had only cardiac manifestations. Six patients presented with de novo heart failure and one had decompensated heart failure. A set of three patients had individually fulminant myocarditis, probable pulmonary embolism and stress cardiomyopathy, respectively.
Conclusions:
This study shows that co-morbidities are common in patients with COVID-19 and cardiac complications. The array of cardiac complications is large, with the commonest being heart failure.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
03:53Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Introduction Cardiac Emergencies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies